Figure 2From: Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemiamiR-16 expression level is stable in both healthy controls and AML patients. MiR-16 expression levels were assessed by qRT-PCR and normalized by cel-miR-39. Shown are the relative levels (mean ± S.D.) of five independent experiments performed on all participants, each done in triplicate.Back to article page